Wisconsin Registry for Alzheimer Prevention: Biomarkers of Preclinical AD

威斯康星州阿尔茨海默病预防登记处：临床前 AD 的生物标志物

• 批准号: 7795781
• 负责人: Mark Sager
• 金额: $ 72.19万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-15 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7795781
• 关键词: Adult Children; Adverse effects; Affect; Age; Alleles; Alzheimer disease prevention; Alzheimer' s Disease; Alzheimer' s disease risk; Amyloid beta-Protein; Apolipoprotein E; Apolipoproteins; Archives; Biological Markers; Blood Vessels; Brain; Brain region; Cerebrospinal Fluid; Child; Cognition; Cognitive; Cognitive aging; Cohort Studies; Control Groups; Country; Data; Dementia; Development; Disease; Disease Progression; Early Diagnosis; Early treatment; Economics; Environmental Health; Episodic memory; Evaluation; Exhibits; Family history of; Family member; Functional Imaging; Functional Magnetic Resonance Imaging; Genetic; Genetic Risk; Genotype; Goals; Health; Heredity; Hippocampus (Brain); Impaired cognition; Individual; Inherited; Intervention; Knowledge; Laboratories; Learning; Life Style; Memory; Neurobiology; Neuropsychological Tests; Onset of illness; Parents; Participant; Pattern; Persons; Plasma; Positioning Attribute; Prevalence; Prevention strategy; Primary Prevention; Prospective Studies; Registries; Research; Research Personnel; Risk; Risk Factors; Sampling; Siblings; Structure; Syndrome; Testing; Universities; Wisconsin; age related; aging brain; apolipoprotein E-4; brain volume; cognitive change; cognitive function; cohort; disorder control; executive function; experience; high risk; middle age; neuropsychological; pre-clinical; prevent; programs; prospective; social

DESCRIPTION (provided by applicant): The expected rapid increase in the prevalence of Alzheimer's disease (AD) will have a significant impact on the economic and social structure of this country and as a result, there is a critical need for research focusing on developing early intervention and prevention strategies. One approach to developing primary prevention strategies for AD is to study cognitive and neurobiological changes occurring in middle-aged individuals who do not have dementia but may be at increased risk for developing the disease. One such group is the adult children of persons with AD who are at increased risk of developing the disease due to heredity, environmental and health risk factors shared with affected parents. The University of Wisconsin is prepared to conduct such a study because of the existence of the Wisconsin Registry for Alzheimer's Prevention (WRAP). WRAP focuses specifically on adult children of persons with AD in an effort to facilitate early detection and develop strategies to reduce the risk of developing AD. To date, we have archived DMA, plasma and serum samples and conducted extensive assessments on over 825 adult children of persons with AD and control subjects without a family history. The purpose of this prospective cohort study is to conduct a second wave of laboratory and neuropsychological testing and structural and functional MRI in order to define patterns and predictors of cognitive change over a 4-year re-test interval. Our long term goal is to identify health and lifestyle variables associated with abnormal cognitive aging and the development of AD and to use this information to develop interventions that will prevent or delay the onset of the disease. Our overall hypothesis is that adult children of persons with AD will exhibit signs of abnormal cognitive aging with declines in learning, memory and executive function and volumetric and fMRI abnormalities that will be predicted by specific genetic, vascular and lifestyle risk factors for AD. The Specific Aims are: 1) determine the differential effects of family history of AD and apolipoprotein (APOE) 4 allele on the cognitive aging of participants; 2) determine the effects of vascular and lifestyle risk factors on the cognitive aging of participants; and 3) examine the differential effect of family history of AD and the APOE 4 allele on brain aging as determined by rates of longitudinal decline in brain volume and fMRI activation during episodic memory tests that are known to activate regions of the brain affected by AD.

描述（由申请人提供）：阿尔茨海默病（AD）患病率的预期快速增长将对该国的经济和社会结构产生重大影响，因此，迫切需要开展重点研究，制定早期干预和预防策略。制定AD一级预防策略的一种方法是研究中年人的认知和神经生物学变化，这些中年人没有痴呆症，但可能有更高的患病风险。一个这样的群体是AD患者的成年子女，他们由于与受影响的父母共享的遗传、环境和健康风险因素而处于发展疾病的增加的风险中。由于威斯康星州老年痴呆症预防登记处（WRAP）的存在，威斯康星州大学准备进行这样的研究。WRAP特别关注AD患者的成年子女，以促进早期发现并制定战略以降低AD的风险。到目前为止，我们已经存档了DMA，血浆和血清样本，并对超过825名AD患者的成年儿童和无家族史的对照受试者进行了广泛的评估。这项前瞻性队列研究的目的是进行第二波实验室和神经心理学测试以及结构和功能MRI，以确定4年复检间隔内认知变化的模式和预测因素。我们的长期目标是 确定与异常认知老化和AD发展相关的健康和生活方式变量，并利用这些信息制定预防或延迟疾病发作的干预措施。我们的总体假设是，AD患者的成年子女将表现出异常认知老化的迹象，学习，记忆和执行功能下降，体积和功能磁共振成像异常，这将通过AD的特定遗传，血管和生活方式风险因素预测。具体目标是：1）确定AD家族史和载脂蛋白（apolipoprotein，APOE）4等位基因对参与者认知老化的不同影响：2）确定血管和生活方式危险因素对参与者认知老化的影响;和3）通过脑容量纵向下降率和功能磁共振成像激活率来检测AD家族史和APOE 4等位基因对脑老化的不同影响在情景记忆测试期间，已知激活受AD影响的大脑区域。